Accounting for Share-Based Awards in a US IPO: Applying ASC 718

The US Securities and Exchange Commission’s (SEC) 2024 enforcement sweep targeting pre-IPO equity grant practices, combined with the Public Company Accounting Oversight Board’s (PCAOB) 2025 inspection priorities, has placed share-based compensation accounting under the sharpest regulatory scrutiny in a decade. For Hong Kong-headquartered companies pursuing a New York Stock Exchange (NYSE) or NASDAQ listing, the application of Accounting Standards Codification (ASC) 718 — Compensation — Stock Compensation — is no longer a routine disclosure item but a material risk factor that can delay SEC qualification, inflate offering proceeds volatility, and trigger post-IPO restatements. The SEC’s Division of Corporation Finance, in its 2025 review comments, has specifically targeted issuers that grant options or restricted stock units (RSUs) within the 12-month window preceding an IPO filing, demanding granular fair-value measurement justifications under ASC 718-10-30. For sponsors and auditors advising Mainland Chinese and Hong Kong issuers — many of which operate through Cayman Islands or BVI holding structures with PRC operating subsidiaries — the interplay between ASC 718’s grant-date recognition requirements and the SEC’s stricter guidance on compensatory versus equity-linked instruments creates a compliance matrix that demands precise, data-backed navigation.

The Grant Date Determination Trap Under ASC 718-10-25

The single most contested area in pre-IPO share-based compensation accounting is the identification of the “grant date” under ASC 718-10-25-2. The standard defines grant date as the date on which an employer and an employee reach a mutual understanding of the key terms and conditions of a share-based payment award. For Hong Kong issuers accustomed to the more flexible approach under Hong Kong Financial Reporting Standard (HKFRS) 2, which permits a “grant date” based on board resolution without requiring employee acknowledgement, the ASC 718 framework imposes a materially higher evidentiary bar.

Board Approval Alone Is Insufficient

The SEC’s 2024 Staff Accounting Bulletin (SAB) No. 121, issued in November 2024, explicitly clarified that board approval alone does not constitute grant date under ASC 718 if the employee has not been informed of the award’s key terms — specifically the number of shares, exercise price, vesting schedule, and expiration date. For a Hong Kong-incorporated company using a Cayman Islands holding company as the listing vehicle, this creates a timing mismatch. The typical sequence — board resolution in Hong Kong, followed by issuance of award letters to employees in the PRC, then execution of subscription agreements — can span 14 to 21 business days. During this window, the fair value of the underlying shares may shift materially, particularly if the company is simultaneously conducting a funding round that establishes a new 409A valuation.

Data from the SEC’s 2025 comment letter database shows that 37% of China-based issuers filing F-1 registration statements between January 2024 and June 2025 received at least one comment letter specifically challenging the grant date determination. The most common deficiency: the issuer treated the board resolution date as the grant date without providing evidence that employees had been notified of the award terms within a contemporaneous timeframe. The SEC’s position is rooted in ASC 718-10-55-12, which requires that the grant date be the date on which the employee’s “right to rely on the terms of the award” is established.

Practical Consequence for Pre-IPO Option Grants

For issuers that granted stock options to key management personnel in the 12 months preceding the IPO filing, the grant date determination directly affects the measurement date for fair value. Under ASC 718-20-35, the compensation cost for an equity-classified award is measured at the grant date and not subsequently remeasured. If the SEC determines that the grant date occurred later than the issuer’s recorded date — for example, on the date the employee signed the award agreement rather than the board resolution date — the fair value must be recalculated using the later date’s share price.

Consider a Hong Kong-based fintech company that granted 1,000,000 options to its CEO on 15 March 2025, using a board resolution that referenced a 409A valuation of HKD 45.00 per share. The employee signed the award agreement on 5 April 2025, by which time a Series C funding round had closed at HKD 52.00 per share. Under the issuer’s original treatment, the compensation expense was HKD 45.00 per option. Under the SEC’s likely position, the grant date is 5 April 2025, producing a fair value of HKD 52.00 per option — a 15.6% increase in total compensation cost. For a 1,000,000-option grant with a Black-Scholes value of approximately HKD 18.00 per option, the incremental expense is HKD 7.00 million, or approximately USD 900,000, which must be recognized over the vesting period.

Fair Value Measurement and the 409A Valuation Gap

ASC 718 requires that all share-based payments be measured at fair value on the grant date. For non-public entities, this typically relies on a Section 409A valuation performed by a qualified independent appraiser. However, the SEC’s 2025 review guidance has tightened the acceptable methodologies for pre-IPO companies, particularly those with complex capital structures involving multiple classes of common and preferred shares.

The Interaction Between 409A and ASC 718 Fair Values

A 409A valuation is designed to establish the fair market value of common shares for U.S. tax purposes, specifically to avoid the imposition of additional tax under Internal Revenue Code Section 409A. This valuation often produces a lower per-share value than the fair value required for ASC 718 financial reporting, because 409A valuations typically apply a discount for lack of marketability (DLOM) and a discount for lack of control (DLOC) that may be more aggressive than what ASC 718 permits.

The SEC’s Division of Corporation Finance, in a series of 2024-2025 comment letters, has pushed back against issuers that use a 409A valuation as the sole basis for ASC 718 fair value without reconciling the two. Specifically, the SEC has required issuers to disclose the per-share fair value used for ASC 718 purposes separately from the 409A value, and to explain any material differences. For a Hong Kong issuer with a Cayman Islands holding company that has issued both Series A preferred shares (with liquidation preferences) and common shares, the allocation of enterprise value under the option-pricing method (OPM) or probability-weighted expected return method (PWERM) must be consistent between the 409A analysis and the ASC 718 measurement.

The Impact of Recent Funding Rounds

When a pre-IPO company completes a funding round within the 12 months preceding the IPO, the SEC presumes that the transaction price is the best evidence of fair value for common shares, absent compelling evidence to the contrary. This presumption, articulated in the SEC’s 2024 Staff Guidance on Pre-IPO Equity Grants, directly challenges the common practice of using a 409A valuation that is stale or that applies discounts not supported by the round’s terms.

For example, a PRC-based e-commerce issuer that raised USD 50 million in a Series D round at HKD 60.00 per preferred share in January 2025, and then granted stock options to employees in March 2025 at a 409A valuation of HKD 35.00 per common share, must justify the 41.7% discount. The SEC will examine whether the preferred shares’ liquidation preferences, anti-dilution protections, and voting rights justify the discount, and whether the common shares’ lack of marketability is appropriately quantified. If the SEC concludes that the discount is unsupported, the fair value for ASC 718 purposes must be adjusted upward, increasing compensation expense and reducing reported net income.

Classification: Equity vs. Liability and the Hong Kong Entity Structure

The classification of share-based awards as either equity or liability under ASC 718-10-25-4 has profound implications for both the income statement and the balance sheet. For Hong Kong issuers using a VIE (variable interest entity) structure or a Cayman Islands holding company with PRC operating subsidiaries, the classification analysis is complicated by the legal form of the award and the settlement currency.

The Cash Settlement Trap for PRC Subsidiaries

Under ASC 718-10-25-8, an award is classified as a liability if the entity is required to settle in cash or other assets, or if the award’s settlement is contingent on a future event outside the employee’s control. For PRC-based subsidiaries that grant share appreciation rights (SARs) or phantom stock to local employees — a common practice to avoid foreign exchange control issues under the State Administration of Foreign Exchange (SAFE) Circular 37 — the award is almost always classified as a liability. The compensation cost must be remeasured at each reporting date, creating volatility in the issuer’s consolidated financial statements.

The SEC’s 2025 review of a Hong Kong-headquartered logistics company’s F-1 filing revealed that the issuer had classified phantom stock granted to PRC employees as equity, arguing that the awards would be settled in shares of the Cayman Islands parent. The SEC challenged this classification, noting that the PRC subsidiary’s obligation to deliver cash in lieu of shares under local employment law created a de facto cash settlement obligation. The issuer was required to restate its financial statements for the three most recent fiscal years, reclassifying USD 12.3 million in compensation expense from equity to liability, which increased total liabilities by 8.7% and reduced retained earnings by the same amount.

The Repurchase Feature and ASC 718-20-55-21

A common feature in pre-IPO option plans for Hong Kong issuers is a repurchase right granted to the company upon an employee’s termination for cause. Under ASC 718-20-55-21, if the repurchase price is at fair value, the award remains equity-classified. However, if the repurchase price is at a formulaic amount — such as the lower of fair value or the employee’s original exercise price — the award may be classified as a liability because the employee does not bear the full risks and rewards of equity ownership.

For a family office with a portfolio company planning a US IPO, this distinction matters directly to the valuation of the compensation expense and the balance sheet leverage ratio. A liability-classified award requires quarterly remeasurement, which can introduce earnings volatility that affects the company’s ability to meet debt covenants or maintain a clean financial profile for institutional investors.

Disclosure Requirements Under SEC Regulation S-K Item 402

The SEC’s disclosure requirements for executive compensation under Regulation S-K Item 402 intersect directly with ASC 718 accounting. For Hong Kong issuers filing an F-1 registration statement, the Compensation Discussion and Analysis (CD&A) must include a detailed description of the methodology used to value share-based awards, including the assumptions used in the Black-Scholes or lattice model.

The Grant Date Fair Value Table

Item 402(c)(2)(ix) requires a summary compensation table that includes the grant date fair value of each equity award granted to named executive officers. For issuers that granted multiple awards at different fair values — for example, options granted before and after a funding round — the table must disaggregate each grant, not merely present an aggregate figure. The SEC’s 2025 review of a Chinese biotechnology issuer’s F-1 identified a deficiency where the issuer aggregated three option grants with grant dates spanning five months into a single line item, obscuring the fact that the fair value per share had increased by 28% between the first and third grants.

The Weighted-Average Assumption Disclosure

Item 402(b)(2)(iv) also requires disclosure of the weighted-average assumptions used in the valuation model, including the expected volatility, risk-free rate, expected dividend yield, and expected term. For a Hong Kong issuer with no public trading history, the expected volatility assumption is particularly scrutinized. The SEC has accepted a “peer group” approach, where the issuer uses the historical volatility of a group of comparable publicly traded companies. However, the SEC requires that the peer group be disclosed and that the selection criteria be justified.

A 2025 SEC comment letter to a Hong Kong-based software issuer required the company to explain why it used a peer group of US-listed software companies with a median market capitalization of USD 2.5 billion, when the issuer itself had a pre-money valuation of USD 150 million. The SEC’s position was that the peer group’s volatility was not representative of the issuer’s expected volatility, and the issuer was required to recalculate the fair value using a peer group of smaller-cap companies, which reduced the expected volatility assumption from 65% to 52% and decreased the per-option fair value by 18%.

Actionable Takeaways for Issuers and Advisors

1. Establish grant date documentation protocols that require employee acknowledgement within five business days of board resolution, and maintain a contemporaneous record of communication to satisfy the SEC’s mutual understanding test under ASC 718-10-25-2.
2. Reconcile 409A valuation fair values to ASC 718 fair values in the registration statement’s notes to financial statements, disclosing the per-share amounts for each class of equity and explaining any material differences in methodology or assumptions.
3. Classify all awards granted by PRC operating subsidiaries as liabilities unless the issuer can demonstrate that the subsidiary has no obligation to settle in cash, and ensure that the classification is consistent with the legal form of the award under PRC employment law and SAFE regulations.
4. Disaggregate all executive equity grants in the summary compensation table by individual grant date, providing the grant date fair value per share and the key valuation assumptions for each grant to comply with Item 402(c)(2)(ix).
5. Select a peer group for expected volatility that matches the issuer’s market capitalization, industry, and stage of development, and document the selection criteria in the CD&A to preempt SEC comment letter challenges.